Literature DB >> 22693401

Radiation therapy in early-stage invasive breast cancer.

Ray Lin1, Prabhakar Tripuraneni.   

Abstract

The treatment of breast cancer involves a multi-disciplinary approach with radiation therapy playing a key role. Breast-conserving surgery has been an option for women with early-stage breast cancer for over two decades now. Multiple randomized trials now have demonstrated the efficacy of breast-conserving surgery followed by radiation therapy. With the advancements in breast imaging and the successful campaign for early detection of breast cancer, more women today are found to have early-stage small breast cancers. Patient factors (breast size, tumor location, history of prior radiation therapy, preexisting conditions such as collagen vascular disease, age, having prosthetically augmented breasts), pathological factors (margin status, tumor size, presence of extensive intraductal component requiring multiple surgical excisions), as well as patient preference are all taken into consideration prior to surgical management of breast cancer. Whole-breast fractionated radiation therapy between 5 and 7 weeks is considered as the standard of care treatment following breast-conserving surgery. However, new radiation treatment strategies have been developed in recent years to provide alternatives to the conventional 5-7 week whole-breast radiation therapy for some patients. Accelerated partial breast radiation therapy (APBI) was introduced because the frequency of breast recurrences outside of the surgical cavity has been shown to be low. This technique allows treatments to be delivered quicker (usually 1 week, twice daily) to a limited volume. Often times, this treatment involves the use of a brachytherapy applicator to be placed into the surgical cavity following breast-conserving surgery. Accelerated hypofractionated whole-breast irradiation may be another faster way to deliver radiation therapy following breast-conserving surgery. This journal article reviews the role of radiation therapy in women with early-stage breast cancer addressing patient selection in breast-conserving therapy, a review of pertinent trials in breast-conserving therapy, as well as the different treatment techniques available to women following breast-conserving surgery.

Entities:  

Keywords:  Accelerated partial breast irradiation; Breast brachytherapy; Breast irradiation in early-stage breast cancer; Breast-conserving surgery and radiation; Hypofractionated whole-breast radiation

Year:  2011        PMID: 22693401      PMCID: PMC3244192          DOI: 10.1007/s13193-011-0048-8

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  72 in total

Review 1.  The role of radiation therapy for primary breast cancer.

Authors:  A G Taghian; S N Powell
Journal:  Surg Clin North Am       Date:  1999-10       Impact factor: 2.741

Review 2.  Early breast cancer.

Authors:  John R Benson; Ismail Jatoi; Martin Keisch; Francisco J Esteva; Andreas Makris; V Craig Jordan
Journal:  Lancet       Date:  2009-04-25       Impact factor: 79.321

Review 3.  Declining breast cancer incidence and decreased HRT use.

Authors:  Merethe Kumle
Journal:  Lancet       Date:  2008-08-23       Impact factor: 79.321

4.  Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.

Authors:  Joseph Ragaz; Ivo A Olivotto; John J Spinelli; Norman Phillips; Stewart M Jackson; Kenneth S Wilson; Margaret A Knowling; Christopher M L Coppin; Lorna Weir; Karen Gelmon; Nhu Le; Ralph Durand; Andrew J Coldman; Mohamed Manji
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

5.  Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

Authors:  M Overgaard; P S Hansen; J Overgaard; C Rose; M Andersson; F Bach; M Kjaer; C C Gadeberg; H T Mouridsen; M B Jensen; K Zedeler
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

6.  Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer.

Authors:  Timothy Whelan; Robert MacKenzie; Jim Julian; Mark Levine; Wendy Shelley; Laval Grimard; Barbara Lada; Himu Lukka; Francisco Perera; Anthony Fyles; Ethan Laukkanen; Sunil Gulavita; Veronique Benk; Barbara Szechtman
Journal:  J Natl Cancer Inst       Date:  2002-08-07       Impact factor: 13.506

7.  Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.

Authors:  J Vito Antonucci; Michelle Wallace; Neal S Goldstein; Larry Kestin; Peter Chen; Pamela Benitez; Nayana Dekhne; Alvaro Martinez; Frank Vicini
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-06       Impact factor: 7.038

8.  Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial.

Authors:  Matthew M Poggi; David N Danforth; Linda C Sciuto; Sharon L Smith; Seth M Steinberg; David J Liewehr; Cynthia Menard; Marc E Lippman; Allen S Lichter; Rosemary M Altemus
Journal:  Cancer       Date:  2003-08-15       Impact factor: 6.860

9.  Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).

Authors:  Benjamin D Smith; Douglas W Arthur; Thomas A Buchholz; Bruce G Haffty; Carol A Hahn; Patricia H Hardenbergh; Thomas B Julian; Lawrence B Marks; Dorin A Todor; Frank A Vicini; Timothy J Whelan; Julia White; Jennifer Y Wo; Jay R Harris
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-15       Impact factor: 7.038

10.  A comprehensive clinical 3-dimensional dosimetric analysis of forward planned IMRT and conventional wedge planned techniques for intact breast radiotherapy.

Authors:  Joseph S Herrick; Cory J Neill; Peter F Rosser
Journal:  Med Dosim       Date:  2008       Impact factor: 1.482

View more
  4 in total

1.  Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (¹³¹I-GMSs) following intratumoral injection.

Authors:  Chuan-Chao Li; Jun-Lin Chi; Yu Ma; Jian-Hong Li; Chuan-Qin Xia; Lin Li; Zhuo Chen; Xiao-Li Chen
Journal:  Radiat Oncol       Date:  2014-06-23       Impact factor: 3.481

2.  A Hybrid Computer-aided-diagnosis System for Prediction of Breast Cancer Recurrence (HPBCR) Using Optimized Ensemble Learning.

Authors:  Mohammad R Mohebian; Hamid R Marateb; Marjan Mansourian; Miguel Angel Mañanas; Fariborz Mokarian
Journal:  Comput Struct Biotechnol J       Date:  2016-12-06       Impact factor: 7.271

3.  Differences in Expression of Mitochondrial Complexes Due to Genetic Variants May Alter Sensitivity to Radiation-Induced Cardiac Dysfunction.

Authors:  Rachel A Schlaak; Anne Frei; Gopika SenthilKumar; Shirng-Wern Tsaih; Clive Wells; Jyotsna Mishra; Michael J Flister; Amadou K S Camara; Carmen Bergom
Journal:  Front Cardiovasc Med       Date:  2020-03-05

4.  Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer.

Authors:  Ting-Chun Lin; Chih-Yuan Lin; Kai-Chiun Li; Jin-Huei Ji; Ji-An Liang; An-Cheng Shiau; Liang-Chih Liu; Ti-Hao Wang
Journal:  Radiat Oncol       Date:  2020-03-17       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.